foxo4-dri clinical trials Frontiers FOXO4-DRI: A Breakthrough Peptide Targeting

With the advent of nanotechnology, CLSM technique can be an imaging tool for better understanding of the fate of nanocarriers in delivering drugs into the skin layers and the efficacy of them in the therapies of different skin disorders

P.SachsM.KempkesB.BirchmeierW

For Canadians dealing with or at risk for non-alcoholic fatty liver disease (NAFLD), this dual action on liver fat represents one of the most compelling reasons to consider the combination

Indeed, the current results have demonstrated a clear PKPD relationship for TS inhibition in these patients (Figure 5)

By disrupting this interaction, the peptide releases p53 to trigger apoptosis selectively in senescent cells while sparing healthy cells (Baar et al., 2017)

Even so, as with any product applied to the skin, the possible side effects are the ones common to anything applied to the skin: some people experience irritation, redness, itching or a contact reaction